U.S. Biologics, Advanced Therapies & Medical Devices Manufacturing and Testing



Risky Submissions: Unknown Compounds in Extractables/Leachables Studies Considered Unacceptable by Regulatory Bodies

Over the past year, regulatory agencies have been placing increased emphasis on..

Upcoming Shows

Come see us at: • BioProcess International Conference in Boston, Oct. 4-7..

Gene Therapies

Reduce your time to clinic with WuXi AppTec’s unparalleled technical and regulatory..